News on Runbio Biotech Co.%2C Ltd from BioPortfolio.com http://www.BioPortfolio.com Consolidated Runbio Biotech Co.%2C Ltd news from BioPortfolio.com Wed, 10 Feb 2010 15:40:18 GMT en Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039871&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039871&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445264%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Teva Gets Marketing Rights for Oral Laquinimod in the Nordic and ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039920&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039920&THISHREF=http://c.moreover.com/click/here.pl%3fz2538473534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039920&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039920&THISHREF=http://c.moreover.com/click/here.pl%3fz2538473534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCalifornia Chronicle: BiomedReports: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com Japan: BiomedReports: News and FDA Updates for PPD (Nasdaq:PPDI), Repros Therapeutics (Nasdaq:RPRX), Stem Cell Theraphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039165&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039165&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039165&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039165&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com Japan: ChemGenex May Face Panel Queries About Omapro Responsehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039491&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039491&THISHREF=http://c.moreover.com/click/here.pl%3fz2538152716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039491&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039491&THISHREF=http://c.moreover.com/click/here.pl%3fz2538152716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: SADIF Analytics releases new summary due diligence report for Hua Han Bio-Pharmaceutical Holdings Ltdhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042233&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042233&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363863%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042233&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042233&THISHREF=http://c.moreover.com/click/here.pl%3fz2539363863%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Clopidogrel Therapy: Research from Sankyo Co., Ltd. in the area of clopidogrel therapy publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041190&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041190&THISHREF=http://c.moreover.com/click/here.pl%3fz2539026339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041190&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041190&THISHREF=http://c.moreover.com/click/here.pl%3fz2539026339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Acacia Pharma Ltd-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040250&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040250&THISHREF=http://c.moreover.com/click/here.pl%3fz2538675550%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040250&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040250&THISHREF=http://c.moreover.com/click/here.pl%3fz2538675550%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Gamida-Teva blood-cancer-drug trial to go forwardhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042383&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042383&THISHREF=http://c.moreover.com/click/here.pl%3fz2539410333%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042383&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042383&THISHREF=http://c.moreover.com/click/here.pl%3fz2539410333%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Chttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042098&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042098&THISHREF=http://c.moreover.com/click/here.pl%3fz2539313840%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4042098&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4042098&THISHREF=http://c.moreover.com/click/here.pl%3fz2539313840%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: CRM qualifies photometric linearity in HPLC diode array systems more safelyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043044&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043044&THISHREF=http://c.moreover.com/click/here.pl%3fz2539591684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4043044&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4043044&THISHREF=http://c.moreover.com/click/here.pl%3fz2539591684%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Technology: Alliance Pharma agrees acquisition of Cambridge Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041300&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041300&THISHREF=http://c.moreover.com/click/here.pl%3fz2539063084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041300&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041300&THISHREF=http://c.moreover.com/click/here.pl%3fz2539063084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comM2: Alliance Pharma agrees acquisition of Cambridge Laboratorieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041272&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041272&THISHREF=http://c.moreover.com/click/here.pl%3fz2539057682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041272&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041272&THISHREF=http://c.moreover.com/click/here.pl%3fz2539057682%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Teva Acquires Marketing Rights For Oral Laquinimod In The Nordic And Baltic Regionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033853&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033853&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033853&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Runbio%20Biotech%20Co.,%20Ltd&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033853&THISHREF=http://c.moreover.com/click/here.pl%3fz2535445039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: